|
1
|
Ilango S, Paital B, Jayachandran P, Padma
PR and Nirmaladevi R: Epigenetic alterations in cancer. Front
Biosci (Landmark Ed). 25:1058–1109. 2020.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Damiescu R, Efferth T and Dawood M:
Dysregulation of different modes of programmed cell death by
epigenetic modifications and their role in cancer. Cancer Lett.
584(216623)2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Feng Y, Spezia M, Huang S, Yuan C, Zeng Z,
Zhang L, Ji X, Liu W, Huang B, Luo W, et al: Breast cancer
development and progression: Risk factors, cancer stem cells,
signaling pathways, genomics, and molecular pathogenesis. Genes
Dis. 5:77–106. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lee S, Rauch J and Kolch W: Targeting MAPK
signaling in cancer: Mechanisms of drug resistance and sensitivity.
Int J Mol Sci. 21(1102)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dong C, Wu J, Chen Y, Nie J and Chen C:
Activation of PI3K/AKT/mTOR pathway causes drug resistance in
breast cancer. Front Pharmacol. 12(628690)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mangé A, Coyaud E, Desmetz C, Laurent E,
Béganton B, Coopman P, Raught B and Solassol J: FKBP4 connects
mTORC2 and PI3K to activate the PDK1/Akt-dependent cell
proliferation signaling in breast cancer. Theranostics.
9:7003–7015. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Palmer N and Kaldis P: Less-well known
functions of cyclin/CDK complexes. Semin Cell Dev Biol. 107:54–62.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ding L, Cao J, Lin W, Chen H, Xiong X, Ao
H, Yu M, Lin J and Cui Q: The roles of cyclin-dependent kinases in
cell-cycle progression and therapeutic strategies in human breast
cancer. Int J Mol Sci. 21(1960)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Al Bitar S and Gali-Muhtasib H: The role
of the cyclin dependent kinase inhibitor p21cip1/waf1 in
targeting cancer: Molecular mechanisms and novel therapeutics.
Cancers (Basel). 11(1475)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Menon SS, Guruvayoorappan C, Sakthivel KM
and Rasmi RR: Ki-67 protein as a tumour proliferation marker. Clin
Chim Acta. 491:39–45. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Burcombe R, Wilson GD, Dowsett M, Khan I,
Richman PI, Daley F, Detre S and Makris A: Evaluation of Ki-67
proliferation and apoptotic index before, during and after
neoadjuvant chemotherapy for primary breast cancer. Breast Cancer
Res. 8(R31)2006.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Liyanage UE, Law MH, Han X, An J, Ong JS,
Gharahkhani P, Gordon S, Neale RE and Olsen CM: 23andMe Research
Team et al. Combined analysis of keratinocyte cancers
identifies novel genome-wide loci. Hum Mol Genet. 28:3148–3160.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sae-Lao T, Tohtong R, Bates DO and
Wongprasert K: Sulfated galactans from red seaweed Gracilaria
fisheri target EGFR and inhibit cholangiocarcinoma cell
proliferation. Am J Chin Med. 45:615–633. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sae-Lao T, Luplertlop N, Janvilisri T,
Tohtong R, Bates DO and Wongprasert K: Sulfated galactans from the
red seaweed Gracilaria fisheri exerts anti-migration effect on
cholangiocarcinoma cells. Phytomedicine. 36:59–67. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Fan J, Zhu J, Zhu H, Zhang Y and Xu H:
Potential therapeutic target for polysaccharide inhibition of colon
cancer progression. Front Med (Lausanne).
10(1325491)2024.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rudtanatip T, Somintara S, Sakaew W,
El-Abid J, Cano ME, Jongsomchai K, Wongprasert K and Kovensky J:
Sulfated galactans from Gracilaria fisheri with supplementation of
octanoyl promote wound healing activity in vitro and in vivo.
Macromol Biosci. 22(e2200172)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Srimongkol P, Songserm P, Kuptawach K,
Puthong S, Sangtanoo P, Thitiprasert S, Thongchul N, Phunpruch S
and Karnchanatat A: Sulfated polysaccharides derived from marine
microalgae, Synechococcus sp. VDW, inhibit the human colon cancer
cell line Caco-2 by promoting cell apoptosis via the JNK and p38
MAPK signaling pathway. Algal Res. 69(102919)2023.
|
|
18
|
Aslama A, Bergerb MR, Ullaha I, Hameeda A
and Masoodc F: Preparation and evaluation of cytotoxic potential of
paclitaxel containing poly-3-hydroxybutyrate-co-3-hydroxyvalarate
(PTX/PHBV) nanoparticles. Braz J Biol. 83(e275688)2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Dehghani N, Tafvizi F and Jafari P: Cell
cycle arrest and anti-cancer potential of probiotic
Lactobacillus rhamnosus against HT-29 cancer cells.
Bioimpacts. 11:245–252. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Intuyod K, Hahnvajanawong C, Pinlaor P and
Pinlaor S: Anti-parasitic drug ivermectin exhibits potent
anticancer activity against gemcitabine-resistant
cholangiocarcinoma in vitro. Anticancer Res. 39:4837–4843.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shendge AK, Basu T and Mandal N:
Evaluation of anticancer activity of Clerodendrum viscosum
leaves against breast carcinoma. Indian J Pharmacol. 53:377–383.
2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Marquette C and Nabell L:
Chemotherapy-resistant metastatic breast cancer. Curr Treat Options
Oncol. 13:263–275. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
He X, Xue M, Jiang S, Li W, Yu J and Xiang
S: Fucoidan promotes apoptosis and inhibits EMT of breast cancer
cells. Biol Phram Bull. 42:442–447. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chantree P, Na-Bangchang K and Martviset
P: Anticancer activity of fucoidan via apoptosis and cell cycle
arrest on cholangiocarcinoma cell. Asian Pac J Cancer Prev.
22:209–217. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wongprasert K, Rudtanatip T and Praiboon
J: Immunostimulatory activity of sulfated galactans isolated from
the red seaweed Gracilaria fisheri and development of resistance
against white spot syndrome virus (WSSV) in shrimp. Fish Shellfish
Immunol. 36:52–60. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li N, Wang C, Georgiev MI, Bajpai VK,
Tundis R, Simal-Gandara J, Lu X, Xiao J, Tang X and Qiao X:
Advances in dietary polysaccharides as anticancer agents:
Structure-activity relationship. Trends Food Sci Technol.
111:360–377. 2021.
|
|
29
|
Lu J, Shi KK, Chen S, Wang J, Hassouna A,
White LN, Merien F, Xie M, Kong Q, Li J, et al: Fucoidan extracted
from the New Zealand Undaria pinnatifida-physicochemical
comparison against five other fucoidans: Unique low molecular
weight fraction bioactivity in breast cancer cell lines. Mar Drugs.
16(461)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang Y, Xing M, Cao Q, Ji A, Liang H and
Song S: Biological activities of fucoidan and the factors mediating
its therapeutic effects: A review of recent studies. Mar Drugs.
17(183)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sakaew W, Somintara S, Jongsomchai K, El
Abid J, Wongprasert K, Kovensky J and Rudtanatip T: Octanoyl
esterification of low molecular weight sulfated galactan enhances
the cellular uptake and collagen expression in fibroblast cells.
Biomed Rep. 19(99)2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Davey MG, Hynes SO, Kerin MJ, Miller N and
Lowery AJ: Ki-67 as a prognostic biomarker in invasive breast
cancer. Cancers (Basel). 13(4455)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yang C, Zhang J, Ding M, Xu K, Li L, Mao L
and Zheng J: Ki67 targeted strategies for cancer therapy. Clin
Transl Oncol. 20:570–575. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Li LT, Jiang G, Chen Q and Zheng JN: Ki67
is a promising molecular target in the diagnosis of cancer
(review). Mol Med Rep. 11:1566–1572. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ma L, Xu GB, Tang X, Zhang C, Zhao W, Wang
J and Chen H: Anti-cancer potential of polysaccharide extracted
from hawthorn (Crataegus.) on human colon cancer cell line HCT116
via cell cycle arrest and apoptosis. J Funct Foods.
64(103677)2020.
|
|
36
|
Abdala-Díaz RT, Casas-Arrojo V,
Castro-Varela P, Riquelme C, Carrillo P, Medina MA, Cárdenas C,
Becerra J and Pérez Manríquez C: Immunomodulatory, antioxidant, and
potential anticancer activity of the polysaccharides of the fungus
Fomitiporia chilensis. Molecules. 29(3628)2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Akhtar MJ, Ahamed M, Alhadlaq HA,
Alrokayan SA and Kumar S: Targeted anticancer therapy:
Overexpressed receptors and nanotechnology. Clin Chim Acta.
436:78–92. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Cheng JJ, Chang CC, Chao CH and Lu MK:
Characterization of fungal sulfated polysaccharides and their
synergistic anticancer effects with doxorubicin. Carbohydr Polym.
90:134–139. 2012.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Asghar U, Witkiewicz AK, Turner NC and
Knudsen ES: The history and future of targeting cyclin-dependent
kinases in cancer therapy. Nat Rev Drug Discov. 14:130–146.
2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Finn RS, Aleshin A and Slamon DJ:
Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen
receptor-positive breast cancers. Breast Cancer Res.
18(17)2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Gopinathan L, Tan SL, Padmakumar VC,
Coppola V, Tessarollo L and Kaldis P: Loss of Cdk2 and cyclin A2
impairs cell proliferation and tumorigenesis. Cancer Res.
74:3870–3879. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Jen CI, Lu MK, Lai MN and Ng LT: Sulfated
polysaccharides of Laetiporus sulphureus fruiting bodies exhibit
anti-breast cancer activity through cell cycle arrest, apoptosis
induction, and inhibiting cell migration. J Ethnopharmacol.
321(117546)2024.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Chen PH, Chiang PC, Lo WC, Su CW, Wu CY,
Chan CH, Wu YC, Cheng HC, Deng WP, Lin HK and Peng BY: A novel
fucoidan complex-based functional beverage attenuates oral cancer
through inducing apoptosis, G2/M cell cycle arrest and retarding
cell migration/invasion. J Funct Foods. 85(104665)2021.
|
